Actinogen Medical Limited
ATGGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -40.85% | -41.96% | -- |
| Total Revenue | -- | -- | -40.85% | -41.96% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -40.85% | -41.96% | -- |
| SG&A Expenses | 17.39% | 13.80% | 15.23% | 13.08% | 5.24% |
| Depreciation & Amortization | 4.70% | 1.47% | 4.30% | 2.23% | -4.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.99% | 55.10% | 14.20% | 12.06% | -33.45% |
| Operating Income | -37.41% | -33.21% | -324.12% | -316.19% | 28.26% |
| Income Before Tax | -39.91% | -35.63% | -328.85% | -320.81% | 29.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.91% | -35.63% | -328.85% | -320.81% | 29.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.91% | -35.63% | -328.85% | -320.81% | 29.32% |
| EBIT | -37.41% | -33.21% | -324.12% | -316.19% | 28.26% |
| EBITDA | -38.03% | -33.82% | -360.13% | -351.53% | 28.60% |
| EPS Basic | -33.33% | -33.33% | -250.00% | -250.00% | 50.00% |
| Normalized Basic EPS | -16.67% | -16.67% | -300.00% | -300.00% | 45.45% |
| EPS Diluted | -33.33% | -33.33% | -250.00% | -250.00% | 50.00% |
| Normalized Diluted EPS | -16.67% | -16.67% | -300.00% | -300.00% | 45.45% |
| Average Basic Shares Outstanding | 8.04% | 8.04% | 33.12% | 33.12% | 41.37% |
| Average Diluted Shares Outstanding | 8.04% | 8.04% | 33.12% | 33.12% | 41.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |